Zobrazeno 1 - 10
of 395
pro vyhledávání: '"T Kariyawasam"'
Publikováno v:
Ceylon Journal of Science, Vol 50, Iss 1, Pp 17-28 (2021)
Land degradation is a global challenge leading to loss of biodiversity and ecosystem services. The ever-increasing population and developmental activities make it hard to confine; thus, restoration of highly degraded habitats is the only solution to
Externí odkaz:
https://doaj.org/article/cf82adafb1e04befb9690b8d21928488
Publikováno v:
Frontiers in Neurology, Vol 10 (2019)
Recent unprecedented advances in treatment for spinal muscular atrophy (SMA) enabled patients to access the first approved disease modifying therapy for the condition. There are however many uncertainties, regarding timing of treatment initiation, re
Externí odkaz:
https://doaj.org/article/c7652bb000a746ac8e9c965fb197f35e
Autor:
Michelle A. Farrar, Arlene D’Silva, James Howells, Didu S T Kariyawasam, Karen Herbert, Cindy S.-Y. Lin, Tejaswi Kandula, Kate A. Carey
Publikováno v:
The Journal of Physiology. 600:95-109
Spinal muscular atrophy (SMA) is associated with developmental disruption of motor axons in ventral roots of the spinal cord alongside motor axon degeneration. The pathogenesis of peripheral axonal change during development is pertinent to understand
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of the National Science Foundation of Sri Lanka. 51:81
Autor:
Veronica Wiley, Jacqueline S. Russell, Ian E. Alexander, Didu S T Kariyawasam, Michelle A. Farrar
Publikováno v:
Genetics in Medicine. 22:557-565
To evaluate the implementation of the first statewide newborn screening (NBS) program for spinal muscular atrophy (SMA) in Australia. Processes that hinder and support clinical development, translation, and sustainability of the first primary genetic
Publikováno v:
Developmental medicine and child neurology. 64(5)
Aim This study dynamically designed, evaluated, and implemented the components of an Australian newborn bloodspot screening (NBS) pilot programme for spinal muscular atrophy (SMA). Method We used an implementation-effectiveness study design and conti
Autor:
Veronica Wiley, Arlene D’Silva, Claire E. Wakefield, Michelle A. Farrar, Janine Vetsch, Didu S T Kariyawasam
Publikováno v:
EClinicalMedicine
EClinicalMedicine, Vol 33, Iss, Pp 100742-(2021)
EClinicalMedicine, Vol 33, Iss, Pp 100742-(2021)
Background: Newborn screening (NBS) for spinal muscular atrophy (SMA) is a recognised model through which health outcomes can be improved. However, perspectives of parents and healthcare professionals (HCPs) involved in such programs are largely unkn
Publikováno v:
Journal of neurology, neurosurgery, and psychiatry. 91(8)
Gene therapy (GT) has tremendous potential for the treatment of neurological disorders to transform patient care. The successful application of virus-mediated GT to treat spinal muscular atrophy is a significant milestone, serving to accelerate simil
Publikováno v:
Frontiers in Neurology, Vol 10 (2019)
Frontiers in Neurology
Frontiers in Neurology
Recent unprecedented advances in treatment for spinal muscular atrophy (SMA) enabled patients to access the first approved disease modifying therapy for the condition. There are however many uncertainties, regarding timing of treatment initiation, re